"Our Manifesto Where science and agility integrate and combine. Cutting through silos across a range of drug development capabilities. Saving precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast."

During the past decade, Quotient Clinical conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 11 clinical trials were completed, i.e. on average, 12.9% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 6 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Quotient Clinical" #1 sponsor was "Corcept Therapeutics" with 9 trials, followed by "Galapagos NV" with 7 trials sponsored, "BioCryst Pharmaceuticals" with 4 trials sponsored, "H. Lundbeck A/S" with 3 trials sponsored and "Kadmon Corporation, LLC" with 3 trials sponsored. Other sponsors include 64 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Quotient Clinical" #1 collaborator was "Quotient Clinical" with 13 trials as a collaborator, "Quotient Sciences" with 9 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Supernus Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Quotient Clinical" are "Healthy" (37 trials), "Healthy Volunteers" (15 trials), "Hereditary Angioedema" (4 trials), "Pharmacokinetics" (3 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Quotient Clinical" in a lesser frequency.

Most popular intervention types in "Quotient Clinical" are "Drug" (94 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Prednisone" (3 trials), "BCX4161" (2 trials), "Glucose" (2 trials) and "Itraconazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Quotient Clinical" are 49 trials for "All" genders, 45 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Quotient Clinical". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 91 completed trials in Quotient Clinical, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Quotient Clinical, 93 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".